SeqWell: Amy Liao

SeqWell has appointed Amy Liao to its board of directors. Liao is CEO of Couragene. She was president of Azenta Life Sciences Services following that firm's acquisition of Genewiz, where she was CEO and cofounder. She holds a PhD in biochemistry and cell biology from Stony Brook University.